The T allele of the hepatic lipase promoter variant C-480T is associated with increased fasting lipids and HDL and increased preprandial and postprandial LpCIII:B European Atherosclerosis Research Study (EARS) II

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 2, 1999, Pages 303-308

  Jansen, Hans ^a   Chu, Grace ^b   Ehnholm, Christian ^c   Dallongeville, Jean ^d   Nicaud, Viviane ^e   Talmud, Philippa J ^b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d INSTITUT PASTEUR DE LILLE   (France)

^e HÔPITAL BROUSSAIS   (France)

Author keywords

Gene promoter; Hepatic lipase; Lipoproteins; Polymorphisms; Postprandial

Indexed keywords

APOLIPOPROTEIN A; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPID; LIVER TRIACYLGLYCEROL LIPASE; TRIACYLGLYCEROL;

ADULT; ALLELE; ARTICLE; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; DNA POLYMORPHISM; ENZYME ACTIVITY; FAMILY HISTORY; FAT INTAKE; GENOTYPE; HEART INFARCTION; HUMAN; LIPID BLOOD LEVEL; MALE; NORMAL HUMAN; PATIENT SELECTION; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0033045098     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.2.303     Document Type: Article

References (43)

1. Jansen H, Hülsmann WC. Enzymology and physiological role of hepatic lipase. Biochem Soc Trans. 1985;13:24-26.
2. Applebaum-Bowden D. Lipases and lecithin:cholesterol acyltransferase in the control of lipoprotein metabolism. Curr Opin Lipidol. 1995;6: 130-135. Review.
3. 2 in man. Atherosclerosis. 1980;36:589-593.
4. De Bruin TWA, Brouwer CB, Gimpel JA, Erkelens DW. Postprandial decrease in HDL cholesterol and HDL apo A-I in normal subjects in relation to triglyceride metabolism. Am J Physiol. 1991;260:E492-E498.
5. Jansen H, Hop W, van Tol A, Bruschke AVG, Birkenhäger JC. Hepatic lipase and lipoprotein lipase are not major determinants of the low density lipoprotein subclass pattern in human subjects with coronary heart disease. Atherosclerosis. 1994;107:45-54.
6. Tan KCB, Cooper MB, Ling KLE, Griffin BA, Freeman DJ, Packard CJ, Shepherd J, Hales CN, Betteridge DJ. Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin-precursor species and insulin resistance. Atherosclerosis. 1995;113:273-287.
7. Groot PHE, Jansen H, van Tol A. Selective degradation of the high density lipoprotein-2 subfraction by heparin-releasable liver lipase. FEBS Lett. 1981;129:269-272.
8. Jansen H, Hülsmann WC. Heparin-releasable (liver) lipase(s) may play a role in the uptake of cholesterol by steroid-secreting tissues. Trends Biochem Sci. 1980;5:265-268.
9. Johnson WJ, Bamberger MJ, Latta RA, Rap PE, Phillips MC, Rothblat GH. The bidirectional flux of cholesterol between cells and lipoproteins: effects of phospholipid depletion of high density lipoprotein. J Biol Chem. 1986;261:5766-5776.
10. Kadowaki H, Patton GM, Robins SJ. Metabolism of high density lipoprotein lipids by the rat liver: evidence for participation of hepatic lipase in the uptake of cholesteryl ester. J Lipid Res. 1992;33:1689-1698.
11. Marques-Vidai P, Azéma C, Collet X, Vieu C, Chap H, Perret B. Hepatic lipase promotes the uptake of HDL esterified cholesterol by the perfused rat liver: a study using reconstituted HDL particles of defined phospholipid composition. J Lipid Res. 1994;35:373-384.
12. Clay MA, Newnham HH, Forte TM, Barter PI. Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL. Biochim Biophys Acta. 1992;1124:52-58.
13. Hegele RA, Little JA, Vezina C, Maguire GF, Tu L, Wolever TS, Jenkins DJA, Connelly PW. Hepatic lipase deficiency: clinical, biochemical, and molecular genetic characteristics. Arterioscler Thromb. 1993;13: 720-728.
14. Sultan F, Lagrange D, Jansen H, Griglio S. Inhibition of hepatic lipase activity impairs chylomicron remnant-removal in rats. Biochim Biophys Acta. 1990;1042:150-152.
15. Borensztajn J, Getz GS, Kotlar TJ. Uptake of chylomicron remnants by the liver: further evidence for the modulating role of phospholipids. J Lipid Res. 1988;29:1087-1096.
16. Krapp A, Ahle S, Kersting S, Hua Y, Kneser K, Nielsen M, Gliemann J, Beisiegel U. Hepatic lipase mediates the uptake of chylomicrons and β-VLDL into cells via the LDL receptor-related protein (LRP). J Lipid Res. 1996;37:926-936.
17. Ji Z-S, Lauer SJ, Fazio S, Bensadoun A, Taylor JM, Mahley RW. Enhanced binding and uptake of remnant lipoproteins by hepatic lipase-secreting hepatoma cells in culture. J Biol Chem. 1994;269: 13429-13436.
18. Shafi S, Brady SE, Bensadoun A, Havel RJ. Role of hepatic lipase in the uptake and processing of chylomicron remnants in rat liver. J Lipid Res. 1994;35:709-720.
19. Connelly PW, Maguire GF, Lee M, Little JA. Plasma lipoproteins in familial hepatic lipase deficiency. Arteriosclerosis. 1990;10:40-48.
20. Breckenridge WC, Little JA, Alaupovic P, Wang CS, Kuksis A, Kakis G, Lindgren F, Gardiner G. Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. Atherosclerosis. 1982;45:161-179.
21. Brand K, Dugi KA, Brunzell JD, Nevin DN, Santamarina-Fojo S. A novel A→G mutation in intron I of the hepatic lipase gene leads to alternative splicing resulting in enzyme deficiency. J Lipid Res. 1996;37:1213-1223.
22. Knudsen P, Antikainen M, Ehnholm S, Uusi-Oukari M, Tenkanen H, Lahdenperä S, Kahri J, Tilly-Kiesi M, Bensadoun A, Taskinen M-R, Ehnholm C. A compound heterozygote for hepatic lipase gene mutations Leu334→Phe and Thr383→Met: correlation between hepatic lipase activity and phenotypic expression. J Lipid Res. 1996;37:825-834.
23. Hegele RA. The molecular basis of hepatic lipase deficiency. Can Med Assoc J. 1991;145:1277.
24. Jansen H, Verhoeven AJM, Halley DJJ, Kastelein JJP. C-T substitution at -480 of the hepatic lipase (HL) promoter associated with a lowered HL activity. Florence, Italy: 66th Congress of the European Atherosclerosis Society. 1996:20. Abstract.
25. Jansen H, Verhoeven AJM, Weeks L, Kastelein JJP, Halley DJJ, van den Ouweland A, Jukema JW, Seidell JC, Birkenhäger JC. A common C to T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler Thromb Vasc Biol. 1997;17:2837-2842.
26. Tahvanainen E, Syvänne M, Frick MH, Murtomäki-Repo S, Antikainen M, Kesäniemi YA, Kauma H, Pasternak A, Taskinen M-R, Ehnholm C, for the LOCAT Study Investigators. Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. J Clin Invest. 1998;101:956-960.
27. Vega GL, Clark LT, Tang A, Marcovina S, Grundy SM, Cohen JC. Hepatic lipase activity is lower in African American men than in white American men: effects of 5′ flanking polymorphism in the hepatic lipase gene (LIPC). J Lipid Res. 1998;39:228-232.
28. Cai S-J, Wong DM, Chen S-H, Chan L. Structure of the human hepatic triglyceride lipase gene. Biochemistry. 1989;28:8966-8971.
29. Ameis D, Stahnke G, Kobayashi J, McLean J, Lee G, Büscher M, Schotz MC, Will H. Isolation and characterization of the human hepatic lipase gene. J Biol Chem. 1990;265:6552-6555.
30. Guerra R, Wang J, Grundy SM, Cohen JC. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc Natl Acad Sci USA. 1997;94:4532-4537.
31. Murtomäki S, Tahvanainen E, Antikainen M, Tiret L, Nicaud V, Jansen H, Ehnholm C. Hepatic lipase gene polymorphisms influence plasma HDL levels: results from Finish EARS participants. Arterioscler Thromb Vasc Biol. 1997;17:1879-1884.
32. Kandoussi A, Cachera C, Parsy D, Bard JM, Fruchart J-C. Quantitative determination of different apolipoprotein B containing lipoproteins by an enzyme linked immunosorbent assay. J Immunoassay. 1991;12:305-323.
33. Bolla MK, Haddad L, Humphries SE, Winder AF, Day INM. High-throughput method for determination of apoE genotypes with use of restriction digestion analysis by microplate array diagonal gel electrophoresis. Clin Chem. 1995;41:1599-1604.
34. Day INM, Humphries SE. Electrophoresis for genotyping: microtitre array diagonal gel electrophoresis (MADGE) on horizontal polyacrylamide (H-PAGE) gels, Hydrolink or agarose. Anal Biochem. 1994;222: 389-395.
35. McConathy WJ, Gesquiere JC, Bass H, Tartar A, Fruchart J-C, Wang C-S. Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-III. J Lipid Res. 1992;33:995-1003.
36. Kinnunen PKJ, Ehnholm C. Effect of serum and apoC-apoproteins from very low density lipoproteins on human postheparin plasma hepatic lipase. FEBS Lett. 1976;65:354-357.
37. Luc G, Fievet C, Arveiler D, Evans AE, Bard J-M, Cambien F, Fruchart J-C, Ducimetiere P. Apolipoproteins C-III and E in apoB- and non-apoB-containing lipoproteins in two populations at contrasting risk for myocardial infarction: the ECTIM study: Etude Cas Temoin sur Infarctus du Myocarde. J Lipid Res. 1996;37:508-517.
38. Bjorkegren J, Hamsten A, Milne RW. Alterations of VLDL composition during alimentary lipemia. J Lipid Res. 1997;38:301-314.
39. Blankenhorn DH, Alaupovic P, Wickham E, Chin HP, Azen SP. Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts: lipid and nonlipid factors. Circulation. 1990; 81:470-476.
40. Hodis HN, Mack WJ, Azen SP, Alaupovic P, Pogoda JM, LaBree L, Hemphill LC, Kramsch DM, Blankenhorn DH. Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography an a controlled trial of lovastatin. Circulation. 1994;90:42-49.
41. Wang D, Sul HS. Upstream stimulatory factor binding to the E-box at -65 is required for insulin regulation of the fatty acid synthase promoter. J Biol Chem. 1991;272:26367-26374.
42. Girard J, Ferre P, Foufelle F. Mechanisms by which carbohydrates regulate expression of genes for glycolytic and lipogenic enzymes. Annu Rev Nutr. 1997;17:325-352.
43. Kahn A. Transcriptional regulation by glucose in the liver. Biochimie. 1997;79:113-118.